Life Science Resources

Innovation is at the heart of the life sciences. Fill knowledge gaps, fuel growth, and improve performance with agile, responsive help from Business Talent Group’s on-demand life science professionals.

  • The Lasting Impact of COVID-19 on U.S. Pharma Marketing

    The Lasting Impact of COVID-19 on U.S. Pharma Marketing

    How can pharma marketers remain effective and relevant for key customers, patients, and healthcare providers (HCPs) in the time of COVID-19?

    Read
  • Find the perfect life science consultant.

    Start a Project
  • Life Science Lens: On-Demand Talent for Resilience and Agility

    Life Science Lens: On-Demand Talent for Resilience and Agility

    On-demand talent is a critical resource for life science and pharma companies as they innovate to keep pace with market changes, respond to emerging health threats, and adapt to a remote environment.

    Read
  • A Rare Disease Specialist Fluent in the Project Location’s Language

    A Rare Disease Specialist Fluent in the Project Location’s Language

    In an effort to inform its Rare Diseases commercial strategy within a specific country, an F100 pharmaceutical company was looking to gain a deeper understanding of the current competitive...

    Read
  • Innovations in Market Access Consulting: How On-Demand Talent Can Help

    Innovations in Market Access Consulting: How On-Demand Talent Can Help

    It’s not easy to bring a new drug to market. As corporate market access functions evolve to help life science companies streamline the complex process of getting therapies into patients’ hands,...

    Read
  • On-Demand Talent for Innovation, Transformation, and Growth in Life Sciences

    On-Demand Talent for Innovation, Transformation, and Growth in Life Sciences

    Independent talent provide an agile source of critical skills that allow life science leaders to keep pace in a fast-changing environment.

    Read
  • How has 2020 volatility impacted the work of independent talent?

    Get the Report
  • A Risk Management Expert for Medical Device and Combination Products

    A Risk Management Expert for Medical Device and Combination Products

    An F200 pharma company needed an experienced principal risk management engineer to assess current processes and develop improvements to mitigate risk during development and manufacturing of...

    Read
  • Developing Compelling Global Health Policy Narratives and Supporting Evidence

    Developing Compelling Global Health Policy Narratives and Supporting Evidence

    As a part of its global therapeutic area (TA) health policy initiatives, a leading biopharma company needed a new and improved narrative and evidence deck to impress upon policymakers and other...

    Read
  • See our life science and pharma capabilities and talent bios.

    Read More
  • Project Management Lead for Medical Evidence, Research, and Innovation Team

    Project Management Lead for Medical Evidence, Research, and Innovation Team

    An F500 biotech company wanted to engage a consultant to work with its medical evidence, research, and innovation team to create and coordinate several projects related to the generation of...

    Read
  • Managing Patient / HCP Promotions Process in Biopharma

    Managing Patient / HCP Promotions Process in Biopharma

    The U.S. patient access team at an F200 biopharma leader was seeking a strong project manager who would support their market access and marketing teams with patient / HCPs promotions. The client...

    Read
  • Digital Health Strategy Refresh

    Digital Health Strategy Refresh

    An F200 pharma company wanted to implement next generation digital health technologies, which required a thorough review of the existing strategy across three therapeutic areas and a roadmap for...

    Read
  • A Team of Experts to Improve Pharma Manufacturing Control Strategy

    A Team of Experts to Improve Pharma Manufacturing Control Strategy

    Pursuing growth into personalized medicine and safer, more effective drug therapy, an F200 biopharmaceutical company wanted to improve its cross-functional end-to-end control strategy and tactics...

    Read
  • Remote Consulting Jobs: How Top Companies Are Getting Critical Work Done from a Distance

    Remote Consulting Jobs: How Top Companies Are Getting Critical Work Done from a Distance

    Remote work has suddenly become the new normal for independent consultants. Here are the types of work best suited for remote consulting jobs.

    Read
  • How can independent talent help you?

    Let's Talk
  • Early Pipeline Market Access Evaluations

    Early Pipeline Market Access Evaluations

    In the midst of a company-wide reorganization, the Cell Therapy Market Access team at an F200 pharmaceutical company needed a value and access expert to support several projects. Looking for...

    Read
  • Ethical Decision-Making and Supply Chain Efficiency with Janssen's John O'Hara

    Ethical Decision-Making and Supply Chain Efficiency with Janssen's John O'Hara

    John O'Hara, VP of Strategic Initiatives at Janssen, joins us to discuss J&J's framework for ethical decision-making in pharma manufacturing and supply chain related to the COVID-19 pandemic

    Read
  • Pricing and Contracting Oversight for IT Transformation

    Pricing and Contracting Oversight for IT Transformation

    The Global Technology Services Group of an F100 pharmaceutical company wanted to streamline global IT application development and turned to Business Talent Group when they needed support managing...

    Read
  • Navigating a New Reality: Pharmaceutical Detailing in a Digital World

    Navigating a New Reality: Pharmaceutical Detailing in a Digital World

    COVID-19 is sidelining the field reps that life science companies rely on for in-person pharmaceutical detailing. Healthcare marketing strategist Martine Taylor discusses how eDetailing can help.

    Read
  • Navigating a New Reality: Life Science and Pharma Supply Chains in the Era of COVID-19

    Navigating a New Reality: Life Science and Pharma Supply Chains in the Era of COVID-19

    Sandy Torrekens—Lead Strategist for the UK Dept. of Health during the “Swine Flu” pandemic—joins us to discuss how life science and pharma companies can respond to COVID-19 supply chain disruption.

    Read
  • Life Science in the Time of COVID-19

    Life Science in the Time of COVID-19

    Get on-demand talent to help you fuel your critical initiatives, pivot faster, and cover any skills or capacity gaps you may have.

    Download
  • Biopharma in the Time of COVID-19

    Biopharma in the Time of COVID-19

    Get on-demand talent to help you fuel your critical initiatives, pivot faster, and cover any skills or capacity gaps you may have.

    Download
  • Reorganizing the Global Pharmacovigilance Function

    Reorganizing the Global Pharmacovigilance Function

    An F200 pharma company was reevaluating the operating model of its global drug safety and pharmacovigilance functions. Looking for help assessing cost, quality, and productivity impact of...

    Read
  • loading
    Loading More...